6 news items
TELA Bio Appoints Greg Firestone as Chief Commercial Officer
TELA
20 May 24
with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TELA
10 May 24
-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
TELA
15 Apr 24
the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
TELA
8 Apr 24
solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results
TELA
21 Mar 24
that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit
o5cy7bq6od2zajh8j7wol0ehpw5
TELA
20 Mar 24
negative, long-term shareholders are likely upset going into this earnings release
- Prev
- 1
- Next